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Solution Structure of the Methyl-CpG Binding
Domain of Human MBD1 in Complex
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tumor suppressor genes become aberrantly hypermeth-
ylated in cancer cells (Sutcliffe et al., 1994; Baylin et al.,
1998; Costello et al., 2000), while DNA hypomethylation
has been shown to lead to elevated mutational rates
and chromosomal abnormalities, thus associating it with
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observations suggest that DNA methylation also func-Nara 630-0101
tions as a genome integrity system. In addition, DNAJapan
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velopmental syndromes, such as Rett, fragile X, andYokohama City University
ICF syndromes, which result from mutations in factors1-7-29 Suehiro, Tsurumi
involved in DNA methylation (Robertson and Wolffe,Yokohama, Kanagawa 230-0045
2000).Japan
In many cases, sites of DNA methylation are recog-3 Department of Tumor Genetics and Biology
nized by a family of protein factors that contain con-Kumamoto University School of Medicine
served methyl-CpG binding domains (MBDs). To date,2-2-1 Honjo
five family members have been characterized in mam-Kumamoto 860-0811
mals and Xenopus laevis: MeCP2, MBD1, MBD2, MBD3,Japan
and MBD4 (Figure 1A) (Hendrich and Bird, 1998; Wade
et al., 1999; Ballestar and Wolffe, 2001). These MBD-
containing proteins bind specifically to methyl-CpGSummary
pairs, except for mammalian MBD3 and X. laevis MBD3
LF. Studies have shown that MBD binds DNA as a mono-In vertebrates, the biological consequences of DNA
mer, and that binding is independent of the DNA se-methylation are often mediated by protein factors
quence surrounding the methyl-CpG site (Hendrich andcontaining conserved methyl-CpG binding domains
Bird, 1998; Ballestar and Wolffe, 2001).(MBDs). Mutations in the MBD protein MeCP2 cause
MBD-containing proteins function by recruiting vari-the neurodevelopmental disease Rett syndrome. We
ous complexes to methyl-CpG sites. For example,report here the solution structure of the MBD of the
MeCP2 simultaneously binds the Sin3-histone deacety-human methylation-dependent transcriptional regula-
lase complex via its transcriptional repression domaintor MBD1 bound to methylated DNA. DNA binding
and promoters containing methylated CpG sequences,causes a loop in MBD1 to fold into a major and novel
resulting in deacetylation of core histones and subse-DNA binding interface. Recognition of the methyl
quent transcriptional silencing (Nan et al., 1998; Jonesgroups and CG sequence at the methylation site is
et al., 1998). Likewise, MBD2 and MBD3 reside in distinctdue to five highly conserved residues that form a hy-
complexes in the mammalian cell, which link DNA meth-drophobic patch. The structure indicates how MBD
ylation with chromatin modification and transcriptionalmay access nucleosomal DNA without encountering
repression. MBD2 is associated with the MeCP1, a largesteric interference from core histones, and provides
multisubunit complex that contains the first identifieda basis to interpret mutations linked to Rett syndrome
binding affinity to methylated DNA (Meehan et al., 1989;in MeCP2.
Ng et al., 1999). MBD3 forms an Mi-2/NuRD complex
with nucleosome remodeling and histone deacetylase
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activities (Wade et al., 1999; Zhang et al., 1999). Mi-2/
NuRD has no significant affinity for methylated DNA, but
DNA methylation of CpG dinucleotides is a major epige- can be tethered to it in the presence of MBD2. MBD1
netic modification of mammalian genomes and is impor- is a transcriptional regulator, characterized by two or
tant for the regulation of gene activity, genomic stability, three CXXC domains, that binds methylated CpG islands
and chromatin structure (Chen et al., 1998; Bird and from the tumor suppressors p16, VHL, and E-cadherin,
Wolffe, 1999). Differences in DNA-methylation status and imprinted SNRPN genes (Cross et al., 1997; Fujita
have been correlated with diverse biological events, in- et al., 1999). MBD1 inhibits the promoter activities
cluding genome imprinting, inactivation of the X chro- of these genes in a methylation-dependent manner
mosome, embryonic development, and carcinogenesis through cooperation of the MBD, CXXC, and transcrip-
(Ballobio and Willard, 1992; Surani, 1998; Xu et al., 1999; tional repression domains (Ng et al., 2000; Fujita et al.,
Costello et al., 2000). Several lines of evidence, albeit 2000). The repression mechanism of MBD1 may involve
indirectly, indicate that DNA methylation may also be deacetylation, as the deacetylase inhibitor trichostatin
linked to suppression of transcriptional noise, homolo- A can partly overcome the repression (Ng et al., 2000).
gous recombination, transposon mobilization, and para- In contrast to the other family members, MBD4 contains
sitic DNA expression (Bird and Wolffe, 1999; Robertson an enzymatic domain within its polypeptide chain, and
and Wolffe, 2000). Promoter-associated CpG islands in can function by itself as a thymine glycosylase that re-
moves the deamination product at methyl-CpG sites
(Hendrich et al., 1999).4Correspondence: shira@tsurumi.yokohama-cu.ac.jp
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Figure 1. Protein and Oligonucleotide Sequences
(A) Sequence alignment of MBD family members from human (h), mouse (m) and X. laevis (x) (Hendrich and Bird, 1998; Wade et al., 1999).
The numberings shown are for human MBD1 (above) and human MeCP2 (below). Conserved residues are boxed. Red denotes MBD1 residues
interacting with DNA bases; gray identifies residues interacting with the DNA backbone. The secondary structure of human MBD1 in the
complex is indicated at the top. Residues that have been shown to be important for DNA binding through mutational analyses are marked
with asterisks above the sequence. Missense mutations in MeCP2 reported to be associated with Rett syndrome are shown below the
sequence.
(B) Sequence of oligonucleotide used in this study. “mC” represents 5-methyl cytosine. The methyl-CpG site is highlighted in red.
Further importance has been attached to the MBD Results and Discussion
and MBD-containing proteins since the discovery that
Rett syndrome is caused by mutations in the methyl- Structure Determination
CpG binding protein MeCP2 (Amir et al., 1999). Rett A section of human MBD1 encompassing the N-terminal
syndrome is a neurodevelopmental disease, and a lead- MBD domain (residues 1–75) was overexpressed in
ing cause of mental retardation and autistic behavior in Escherichia coli, isotopically labeled, and purified (Fig-
females. Mutational data has been rapidly accumulating ure 1A). The recombinant protein, which binds specifi-
for MeCP2 (reviewed by Van den Veyver and Zoghbi, cally to a methyl-CpG site, was mixed at a 1:1 stoichiom-
2000; Dragich et al., 2000), and mutations of more than etry with a 12 bp palindromic duplex oligonucleotide
17 different residues have been found so far. Intriguingly, containing a methyl-CpG pair (Figure 1B). Preliminary
11 missense mutations cluster on the MBD, further em- DNA binding analysis by electrophoretic mobility shift
phasizing the importance of this domain. assay revealed that this oligonucleotide is sufficiently
A central step to understanding the molecular mecha- long for the methylation-dependent binding of the MBD
nism of the DNA methylation system would be to deter- (data not shown). The complex formed between the 15N-
mine how the methylation signal is read by MBD-con- labeled MBD and the 12 bp oligonucleotide exhibited
taining proteins. Previous analyses, including structural an excellent 1H-15N HSQC spectrum that differed from
determinations of the unliganded MBDs of MBD1 and the unliganded MBD spectrum.
The structure of the MBD-DNA complex was deter-MeCP2 by us and others, have suggested that the basic
mined from a total of 2022 distance and torsional angleconserved protein surface and a loop may form the
restraints, including 91 intermolecular NOE restraints (Fig-interfacial surface with methylated DNA (Ohki et al.,
ure 2A and Supplemental Table S1, available online at1999; Wakefield et al., 1999); however, the mode of pro-
http://www.cell.com/cgi/content/full/105/3/487/DC1).tein-DNA interaction remains largely unknown. Here, we
Figure 3A depicts the protein backbone and DNA heavyreport the solution structure of the MBD of human MBD1
atoms of the final 20 structures derived from the NMRin complex with methylated DNA. We also present muta-
data, showing that the atomic coordinates of residuestional binding data that confirm many of the key interac-
3–69 of the protein and base pairs 3–10 of the DNA havetions observed between MBD and DNA in the NMR
been well defined. The statistics of the structures arestructure. The structure explains how MBD can access
listed in Table S1.exposed CpG sites on nucleosome cores without en-
countering steric interference from core histones, and
also provides a basis to interpret rapidly accumulating Structure of the MBD
The MBD in the complex folds into an a/b sandwichmutational data for MeCP2 from patients suffering from
Rett syndrome. structure comprising a layer of twisted b sheet, backed
Recognition of Methylated DNA by MBD1
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Figure 2. Intermolecular NOEs in the MBD-DNA Complex and Folding of Loop L1 Induced by DNA Binding
(A) Selected region of 2-dimensional (v1)-13C-filtered (v2)-13C-selected and (v2)-13C-filtered NOE spectra at a mixing time of 40 ms, depicting
intermolecular NOEs between the MBD and DNA. Diagonal peaks are denoted by asterisks.
(B) The {1H}-15N NOE values measured for unliganded-MBD (upper) and DNA-bound MBD (lower). Secondary structure elements of the DNA-
bound MBD are indicated. Smaller NOE values imply faster motion of the protein backbone.
by another layer formed by the a1 helix and a hairpin and displays features typical of a B form duplex, except
for a slight widening of the major groove at the MBDloop at the C terminus (Figure 3B). These layers are both
amphipathic, with the a1 helix and the b sheet lying contact site. The heavy atoms in base pairs 3–10 in the
complex have a root-mean-square deviation (rmsd) fromparallel and the hydrophobic faces tightly packed
against each other. The b sheet is composed of two standard B form DNA of 1.5 A˚.
long inner strands (b2 and b3) sandwiched by two
shorter outer strands (b1 and b4). The section of the Recognition of the Methyl-CpG Site
The two methyl groups in the methyl-CpG site are distin-inner strands that projects beyond the outer strands is
embedded in the major groove at the target DNA site guished by major groove contacts made by five MBD
residues, Val-20, Arg-22, Tyr-34, Arg-44, and Ser-45,and, together with the loop (L1) that links b2 and b3,
forms the principal DNA interface (Figure 3B). which form a continuous hydrophobic patch that medi-
ates the contacts (Figures 3C and 4A). Apart from Val-Loop L1 undergoes major structural rearrangements
upon binding DNA: its flexible loop conformation adopts 20, these amino acids are invariant in all functional MBD
family members. The lack of symmetry in the methyl-a well defined hairpin-like structure. The rest of the DNA-
bound MBD has a similar structure to that of the unli- contacting interface indicates that each of the two
methyl groups is recognized in a distinct manner (Figureganded MBDs of MBD1 and MeCP2 (Ohki et al., 1999;
Wakefield et al., 1999). The measured {1H}-15N NOE val- 4B). The methyl group of m5C6 packs into a pocket
formed by the hydrophobic side chains of Val-20 andues for residues in loop L1 in the complex (0.74 6 0.06)
are comparable to those found in the a/b structured Tyr-34, and an aliphatic portion of the Arg-22 side chain.
The other methyl group, m5C18, makes hydrophobicregions, whereas the NOE values for the L1 residues in
the unliganded MBD are much smaller (0.32 6 0.15; contacts with aliphatic portions of the conserved Arg-
44 and Ser-45 residues. These interfacial contacts areFigure 2B), clearly indicating the presence of an induced
fit. The induced hairpin-like structure results from exten- deduced from 19 intermolecular NOE observations be-
tween the methyl groups and these five residues (Fig-sive contacts between the loop and the major groove
of DNA; seven of the nine residues in loop L1 contribute ure 2A).
Recognition of the two guanine bases, G7 and G19,to an interface with just one of the two DNA strands
(Figures 1A and 3B). at the methyl-CpG site, results from interactions with
Arg-22 and Arg-44. The guanidinium of Arg-22 is poisedThe other DNA strand contributes to a second major
interface with residues 44–48 of MBD, comprising loop to donate a hydrogen bond to G7, being held in position
by a hydrogen bond-salt bridge interaction with the car-L2 and the N-terminal part of helix a1 (Figures 1A and
3B). Loop L2 is inserted into the DNA major groove, with boxylate of conserved Asp-32 (Figures 4A and 4B). Arg-
22 also donates a hydrogen bond to the phosphateall its residues projecting outward to make important
base contacts. By contrast, residues in the N-terminal located between C5 and m5C6 through its e-NH, thus
contributing to interfaces with both the base and back-part of helix a1 interact with the sugar-phosphate back-
bone, orientating the N-terminal end of this helix toward bone of the DNA. To G19, the guanidinium group of Arg-
44 is in a position to donate a hydrogen bond, buttressedthe DNA backbone, as often seen in protein-DNA com-
plexes. These contacts to base and backbone anchor by the aromatic ring of Tyr-34. These interfacial contacts
are significant to recognition, as substitution of Arg-22an edge of the b sheet and the N-terminal part of the
a1 helix to the DNA. In the complex, the DNA is unbent or Arg-44 with either alanine or lysine abolishes DNA
Cell
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Figure 3. An Overview of the MBD1 MBD-
DNA Complex
(A) Stereoview of the best-fit superposition of
the 20 final structures. The protein backbone
atoms and DNA heavy atoms (base pairs
2–11) are shown. The disordered two N-ter-
minal and six C-terminal residues of MBD and
the terminal base pairs of the DNA duplex are
omitted from all figures for clarity. The two
methyl groups at the methyl-CpG site are
shown in red.
(B) Stereo ribbon diagram of the energy-mini-
mized averaged structure of the MBD-DNA
complex. Secondary structure elements of
the protein are indicated.
(C) Close-up view of the best-fit superposi-
tion of the final structures, showing conver-
gence of amino acid side chains at the pro-
tein-DNA base interactions in the major
groove. The side chain atoms of Val-20, Arg-
22, Tyr-34, Arg-44, and Ser-45 are shown in
green and the protein backbone is shown in
orange. The two methyl groups at the methyl-
CpG site are shown in red.
binding (Figure 4C). In addition, the side chain-side chain nine and histidine at positions 34 and 30, respectively
(MBD1 numbering; Figure 1A). In contrast, X. laeviscontacts to Arg-22 and Arg-44 provided by Asp-32 and
Tyr-34, respectively, are crucial for generating the cor- MBD3, which is capable of binding specifically to a
methyl-CpG site (Wade et al., 1999), has tyrosine andrect interfacial surface. The existence and importance
of the Asp-32-Arg-22 interaction has been shown by lysine at positions 34 and 30, respectively, which are
homologous to the residues in functional MBD familymutagenesis; substitution of Asp-32 with alanine sig-
nificantly impairs DNA binding, even though Asp-32 members.
Mutation of the patch residue, Ser-45, to alanine, alsoappears not to make a direct contact with DNA (Fig-
ure 4C). causes a reduction in DNA binding (Figure 4C). None of
the mutants shown in Figure 4C showed evidence of aSpecificity for the m5C:G base pair is further conferred
by Tyr-34; its side chain hydroxyl group is poised to disruption in their overall fold caused by the mutation, as
judged by NMR (see Experimental Procedures). Takenaccept a hydrogen bond from the 4-amino group of
m5C6 (Figure 4A). The existence of this bond is sup- together, recognition of the methyl-CpG site appears
to be the result exclusively of hydrophobic and polarported by mutagenesis of Tyr-34 to phenylalanine or
alanine, either of which markedly decreases the affinity contacts made by the five patch residues. Base contacts
by MBD are limited to the m5CG sequence within thefor methylated DNA, suggesting that the Tyr-34 hydroxyl
group participates in DNA binding (Figure 4C). This result major groove.
indicates that the amino acid at position 34, along with
the amino acid at position 30, may account for the differ- Contacts to the DNA Backbone
Most of the contacts to the DNA sugar-phosphate back-ent affinities of mammalian and X. laevis MBD3 for meth-
ylated DNA. Mammalian MBD3, which does not bind to bone are made by residues in loop L1 and helix a1. Loop
L1 (residues 22–30), which becomes ordered upon DNAmethyl-CpG (Hendrich and Bird, 1998), has phenylala-
Recognition of Methylated DNA by MBD1
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Figure 4. Recognition of the Methyl-CpG Site
(A) A detailed view of contacts between the MBD and DNA in the energy-minimized, averaged structure. Protein side chains of residues
interacting with DNA bases and the backbone are shown in yellow and red, respectively. The side chain of Asp-32 is shown in orange. The
protein backbone is shown in green. Red dashed lines indicate proposed intermolecular hydrogen bonds and the Asp-32-Arg-22 interaction.
(B) Schematic summary of protein-DNA contacts. DNA bases are indicated as boxes, the deoxyribose sugar rings as pentagons, and the
phosphates as circles. Methyl groups at the methyl-CpG site are represented as pink circles. Bases, sugars, and phosphates that interact
with the protein are shaded. Arrows are drawn from residues of the MBD to DNA, representing interfacial hydrophobic (yellow), hydrogen
bond (red), and electrostatic (blue) interactions. Red dashed arrows indicate hydrogen bonds involving backbone amide groups.
(C) Electrophoretic mobility shift assay examining the DNA binding capacity of different mutants of the MBD1 MBD. The wild-type and mutated
residues are indicated.
binding, spreads out from the body of the protein, its trast, conservative substitution of Arg-30 to lysine has
little effect on DNA binding, presumably because thetip latching onto the DNA backbone of one strand (Figure
3B). The invariant Gly-25 forms a characteristic sharp positively charged side chain of lysine can make a simi-
lar contact with the DNA backbone. However, lysineturn at the extreme of the loop, and the main chain
amide groups of its neighboring residues (Lys-23, Ser- substitution of either Arg-22 or Arg-44 abolishes DNA
binding, revealing that the guanidinium groups of these24, Ala-26 and Thr-27) are favorably positioned to do-
nate hydrogen bonds to either of the two phosphates residues are crucial for base discrimination as predicted
from the complex structure (Figure 4C). The backbonelocated between C5 and G7 (Figure 4B). Some of these
residues on the loop make simultaneous hydrophobic interaction is further stabilized by two a1 helix residues,
Val-47 and Glu-48, that make hydrophobic contacts withcontacts with the backbone sugars. Helix a1 contributes
its three N-terminal residues to the interface with the deoxyribose rings of C17 and m5C18, respectively (Fig-
ure 4B).backbone of the other DNA strand. These contacts ori-
ent the N-terminal end of this helix toward the DNA
backbone, permitting a favorable interaction of the helix
dipole with the negatively charged DNA backbone. The Protein-DNA Interfacial Area
A remarkable feature of the MBD-DNA interaction is itsAs in other DNA binding proteins, several arginine and
lysine residues interact with the negatively charged DNA small contact area. The calculated change in solvent-
accessible surface area of the MBD upon DNA bindingbackbone including Arg-18, Lys-23, Arg-30, Arg-42, Lys-
46, Arg-51, and Lys-65 (Figure 4B). The importance of is only 810 A˚2, which is much smaller than the average
value of 1340 A˚2 calculated for nine monomeric proteinsArg-30, Lys-46, and Lys-65 to DNA binding has been
shown by alanine substitutions, which significantly de- (Jones et al., 1999). This small value reflects the fact
that the MBD contacts DNA exclusively within a narrowcreased DNA binding in each case (Figure 4C). By con-
Cell
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Figure 5. The Protein-DNA Interfacial Area
(A) The MBD-DNA contacts lie exclusively within the major groove of DNA. The surface of the protein is viewed from the minor groove side
at the methyl-CpG site. Residues interacting with DNA bases and the sugar-phosphate backbone are shown in red and blue, respectively.
(B) A model of the MBD-nucleosome core complex, constructed from the solution structure of the MBD-DNA and the crystal structure of the
nucleosome core particle (Luger et al., 1997). The MBDs are shown in yellow, core histones in blue, DNA bases in gray, and DNA backbone
in white. This model illustrates that the MBD can access methyl-CpG sites exposed in the major groove on nucleosome cores without
encountering steric interference from the core histones.
(C) Schematic ribbon diagrams comparing DNA complexes of the MBD (left), Tn916-INT (middle) (PDB code 1B69; Wojciak et al., 1999), and
AtERF1 (right) (PDB code 1GCC; Allen et al., 1998). The N and C termini are labeled. Residues interacting with DNA bases and the sugar-
phosphate backbone are shown in red and blue, respectively.
area of the major groove of the duplex, and that no part structure is regarded to be in a “compact and inactive”
state. Model building using the coordinates of theof the protein invades the minor groove side (Figure 5A).
This limited interfacial contact area of DNA is probably nucleosome core (PDB code 1AOI) and the MBD-DNA
complex reveal that the infrastructure of the nucleosomenecessary for MBD to bind efficiently to nucleosomal
DNA. The crystal structure of the nucleosome core parti- permits the MBD to coexist on the nucelosome with
nonacetylated core histones (Figure 5B). Indeed, Chandlercle shows that all the core histone/DNA interactions
occur at inward-facing DNA backbone segments or in et al. (1999) have shown that the MBD of MeCP2 can
bind to methyl-CpG sites exposed in the major groovethe minor groove of the outward-facing parts of the
DNA (Luger et al., 1997). Parts of the N-terminal tails of nucleosomal DNA without major impediment. This
ability to bind to nucleosomal DNA characterizes theof histones H2A, H2B, and H3 are embedded in the
outward-facing minor grooves, leaving adjacent major MBD-containing proteins as members of an unusual
group of proteins that include the glucocorticoid recep-grooves untouched. Restricting the MBD contact area
to the DNA major groove is therefore advantageous; tor, the thyroid hormone receptor, HNF3, and histone
H1 (Chandler et al. 1999). In contrast to histone H1,it means that the MBD can access methyl-CpG sites
exposed in the major groove on nucleosome cores with- however, MBD binding to the nucleosome does not ap-
pear to cause rearrangement of the core histone con-out encountering steric interference from any part of the
core histones. tacts with DNA (Guschin et al., 1998; Lee and Hayes,
1998; Chandler et al., 1999). Because the contact sur-In the crystal structure, the histone N-terminal tails of
the nucleosome structure are not acetylated; thus, the face between the DNA and MBD is small, the fold of the
Recognition of Methylated DNA by MBD1
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Figure 6. Rett Syndrome Mutations of MeCP2
(A) A model of the MeCP2 MBD-DNA complex, constructed from the structures of the MBD1 MBD-DNA and the unliganded MBD of MeCP2
(Wakefield et al., 1999), is shown. Schematic ribbon drawing of the model with residues suggested to make contacts with DNA bases (red)
or backbone (orange), viewed along the DNA axis. The two methyl-groups at the methyl-CpG site are shown in a space filling representation.
(B) Known Rett syndrome mutation sites. Surface-exposed residues are shown in red, those buried in the protein core are shown in yellow.
The view is the same as in (A).
(C) Electrostatic potential on the protein surface of the MeCP2 MBD-DNA model complex, viewed from the protein side (left). Blue corresponds
to positive and red to negative potential. Rett syndrome mutation sites (boxed) and residues contributing to the negatively charged patch are
indicated. Missense mutations associated with Rett syndrome are shown in parentheses. The area of the negatively charged surface is circled
by a dotted line. For comparison, the electrostatic potential on the protein surface of the MBD1 MBD-DNA complex is shown (right).
MBD-bound DNA probably deviates little from that of with every other side chain pointing toward the DNA,
standard B form DNA. making extensive contacts with four and five base-pairs
and the backbone of the DNA (Figure 5C) (Connolly et
al., 2000). These b sheet residues dominate binding inComparison with Other DNA Binding Proteins
the major groove. In the Tn916-INT complex, a loopThe secondary structure organization of MBD has simi-
following the b sheet is positioned in the minor groovelarity to those of several other DNA binding proteins
to make additional electrostatic interactions with the(Ohki et al., 1999). Both the DNA binding domains of
DNA backbone. In addition, the C-terminal helices ofTn916 integrase (Tn916-INT) and a GCC-box binding
both Tn916-INT and AtERF1 are remote from the inter-protein, AtERF1, have a sandwich structure formed by
face (Connolly et al., 2000).a three-stranded b sheet and a C-terminal a helix, re-
Striking differences can be seen in the MBD-DNAsembling the MBD (Figure 5C) (Allen et al., 1998; Wojciak
complex. The heavily twisted b sheet is positioned slant-et al., 1999), despite no apparent sequence similarity
ingly within the major groove to wedge the C-terminalbetween the MBD and these proteins.
part of strand b4, rather than lying flat in the grooveThe mode of DNA binding of the MBD is, nevertheless,
(Figure 5C). This orientation of the b sheet of the MBDdifferent from those seen with Tn916-INT and AtERF1.
allows helix a1 and loop L2 to mediate major grooveIn the complexes of Tn916-INT and AtERF1, the face of
three-stranded b sheet lies flat in the DNA major groove contacts with DNA. The largest interface with DNA is
Cell
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made by residues in L1; by contrast, there is no counter- are well conserved among the MBD family, but are lo-
cated away from the DNA interface. Rett mutations af-part of L1 in Tn916-INT or AtERF1. All the contacts made
by the MBD are confined within the major groove and fecting these MeCP2 residues likely have global struc-
tural consequences, because they are presumablybackbone, and involve only two base pairs of DNA (m5C6
and G7); thus no minor groove contact was observed. important for proper folding or for maintaining the pro-
tein’s structure in both MBD1 and MeCP2 (Figure 6B)
(Ohki et al., 1999; Wakefield et al., 1999; Ballestar et al.,Rett Syndrome: Mutations in MeCP2
2000; Free et al., 2001). The mutations R106W and F155SThe strong conservation of residues that are important
have been shown to cause a disruption of the MBD foldfor DNA binding and structural integrity of the domain
(Ballestar et al., 2000; Free et al., 2001)suggests that the folding and mode of DNA interaction
The remaining three residues at known Rett mutationare similar throughout the MBD family. The structure of
sites, Asp-97, Asp-156 and Thr-158, are clustered at thethe MBD-DNA complex thus allows us to interpret the
protein surface away from the DNA interface (Figuresrapidly accumulating mutational data for MeCP2 in pa-
6B and 6C); however, on the basis of their side chaintients suffering from Rett syndrome, a leading cause of
location, mutations at these residues are unlikely tomental retardation and autistic behavior in females.
cause global conformational changes or large reduc-We constructed a model of the MeCP2 MBD-DNA
tions in DNA binding. In fact, previous experiments havecomplex by best-fit superposition of the coordinates of
shown that the Rett mutation T158M causes little reduc-the unliganded MeCP2 MBD (PDB code 1QK9; Wake-
tion in its binding affinity for methylated DNA, comparedfield et al., 1999) to those of the MBD1 MBD bound
with the Rett mutation R133C, which reduces DNA bind-to DNA, as shown in Figure 6. The root-mean-square
ing significantly (Ballestar et al., 2000; Free et al., 2001).deviation between the DNA-bound MBD of MBD1 and
In the MBD family, only MeCP2 and MBD4 possessthe unliganded MBD of MeCP2 is 1.46 A˚ over 23 Ca
a threonine at position 158 (MeCP2 numbering) (Bal-coordinates for residues in the b2, b3, and b4 strands
lestar et al., 2000); MBD1 has a lysine that contributesand the a1 helix. Because the loop equivalent to L1 of
to the DNA backbone interaction (Lys-65 in MBD1; Fig-MBD1 (residues 111–119 in MeCP2) has no known Rett
ure 1A). Adjacent to Thr-158, residues at two Rett muta-mutation site, DNA contacts mediated by this loop are
tion sites, Asp-97 and Asp-156, form a negativelynot discussed here, and the structural rearrangement
charged surface opposite to the DNA interface, togetherthat this loop would undergo upon DNA binding has not
with Glu-143, Asp-147, Asp-151, and Asp-154 (Figurebeen considered in the model. Omitting this loop, all
6C). Apart from Glu-143, these residues are conservedprotein residues that make base contacts and most of
between mammalian and X. laevis MeCP2 but not be-the residues that make backbone contacts are located
tween other MBD family members, indicating that thisat similar positions, relative to the DNA, in the MBD-
surface is unique to the MBD of MeCP2 (Figure 1A). ThisDNA complex and in the model (Figure 6A), suggesting
region of MeCP2 is made up of the N- and C-terminalthe validity of our model. Our model is also consistent
residues of the MBD sequence, and its tertiary structurewith previous chemical shift perturbation and mutational
is significantly different from the corresponding part ofdata for MeCP2 (Wakefield et al., 1999; Ballestar et al.,
MBD1 (Figure 6C). These observations suggest that Thr-2000; Free et al., 2001).
158 and this negatively charged region may be involvedSubstitutions of more than 17 different residues have
in a specific function of MeCP2, such as interacting withbeen reported in MeCP2, 11 of which are in the MBD,
another protein factor or with another domain withinas shown in Figure 1A (Amir et al., 1999; Van den Veyver
MeCP2.and Zoghbi, 2000). The MeCP2 residues Arg-133 and
Ser-134, which are mutated in some cases of Rett syn-
Conclusiondrome, are positioned in close vicinity to DNA bases in
the model (Figure 6B) and are equivalent to Arg-44 and
Methyl-CpG binding proteins have been something ofSer-45 of MBD1—two of the five residues that form the
an enigma; the recognition site is extremely short andhydrophobic methyl binding pockets in the MBD1-DNA
can only be distinguished efficiently by the presence ofcomplex (Figures 1A and 4B). Therefore, it is logical
two methyl groups (Hendrich and Bird, 1998; Ballestarto suggest that either of these Rett mutations causes
and Wolffe, 2001). The extensive interactions betweendefects in contacting the DNA bases, and thus in reading
protein side chains and DNA bases that we have deter-the methylation site. In fact, the Rett mutation R133C
mined here reveal a basis for recognizing symmetrichas been shown to reduce the DNA binding of MeCP2
methyl-CpG sequences. The absence of apparent base-significantly (Yusufzai and Wolffe, 2000; Free et al.,
protein contacts outside the dinucleotide sequence is2001).
consistent with the observation that MBD binding isAnother residue of MeCP2 at a Rett mutation site,
independent of the DNA bases surrounding the CG se-Ala-140, is not conserved between MeCP2 and MBD1;
quence. Finally, our structure provides a framework forand the corresponding residue of MBD1, Arg-51, makes
further studies of Rett syndrome by facilitating the in-a backbone contact in the DNA complex. In the model
terpretation of the accumulating mutational data onof the MeCP2 MBD-DNA complex, Ala-140 is located
MeCP2.relatively near the DNA backbone (Figure 6B); therefore,
the Rett mutation of Ala-140 to valine might cause re-
Experimental Proceduresduced DNA binding affinity through the introduction of
valine’s bulky side chain. NMR Sample Preparation
Five other MeCP2 residues found in the Rett mutation 15N-labeled and 15N/13C-labeled GST-MBD11–75 fusion proteins were
expressed in Escherichia coli strain DH5a grown in synthetic mediasites, Pro-101, Arg-106, Leu-124, Pro-152, and Phe-155,
Recognition of Methylated DNA by MBD1
495
containing 15NH4Cl and 15NH4Cl/13C-glucose, respectively, and puri- intermolecular NOEs. For the protein, cross peaks due to the chemi-
cal exchange process were not observed.fied. After cleavage with thrombin, MBD11–75 with an extra Gly-Ser
sequence at its N terminus, referred to as MBD, was further purified Backbone torsion angle (`,c) restraints in a/b structure regions
were estimated by the backbone vicinal coupling constants (3JHN,Ha)by chromatography. A sample of perdeuterated, 15N-labeled MBD
containing only Arg residues labeled with 13C, 15N, and 1H was ob- or by a database search procedure based on backbone chemical
shifts, using the program TALOS (Cornilescu et al., 1999). The torsiontained by growing E. coli in media (90 atom% D2O) supplemented
with 100 mg/liter 13C, 15N-labeled Arg. The palindromic 12-mer oligo- angles x1 of Trp-15, Tyr-35, Tyr-52, Phe-62, and Phe-64 were esti-
mated from the 3JC9Cg and 3JNCg coupling constants. Those of Asp-7,nucleotide containing a methyl-CpG sequence at natural isotopic
abundance was synthesized chemically and annealed. The MBD- Arg-22, Asp-32, and Tyr-34 were estimated from 3JNHb, 3JC9Cg and/or
3JHaHb couplings, obtained from HNHB, HN(CO)CO, and HACAHBDNA complex was formed by titrating the oligonucleotide into the
protein. Changes in the amide group resonances of the protein in spectra (Vuister et al., 1998).
the 1H-15N HSQC spectrum and in the imino proton resonances of
DNA were used to indicate a 1:1 stoichiometry. The complex was
Structure Determinationconcentrated using a Centricon column for NMR. The MBD-DNA
The structures of the MBD-DNA complex were calculated with simu-complex was in slow exchange on the chemical-shift timescale.
lated annealing protocols, using XPLOR (Bruenger, 1993). The NOESamples for NMR measurements typically comprised 1.3 mM MBD-
connectivities within the protein, and between the protein and DNA,DNA complex in 20 mM potassium phosphate buffer (pH 6.5), 5 mM
were categorized by strong, medium, weak, and very weak crossDTT.
peaks, and assumed to correspond to the upper limits for proton-
proton distances of 3.0, 4.0, 5.0, and 6.0 A˚, respectively. Interproton
distance restraints for the DNA were classified into five ranges,NMR Spectroscopy
NMR spectra were acquired at 303 K using Bruker DMX500, DRX500, 1.8–2.5, 1.8–3.0, 1.8–3.5, 2.3–5.0, and 2.3–6.0 A˚. Experimental re-
straints are listed in Table S1. Distances involving nonstereospecifi-or DRX800 NMR spectrometers. For assignments of the protein 1H,
15N, and 13C resonances, a series of three-dimensional (3D) experi- cally assigned methylene protons and aromatic ring protons in the
protein were represented as a (Sr26)21/6 sum (Omichinski et al., 1997).ments (HNCO, HN(CA)CO, CBCA(CO)NH, CBCANH, C(CO)NH,
H(CCO)NH, and HCCH-TOCSY) was performed (Cavanagh et al., Watson-Crick base pairing was maintained in the DNA by the follow-
ing hydrogen bond restraints: for GC base pairs, rG(N1)2C(N3) 5 2.95 61996). Assignment of 1H chemical shifts of the DNA duplex was
obtained from analysis of 2D (v1, v2)-13C-filtered NOESY and TOCSY 0.2 A˚, rG(N2)2C(O2) 5 2.86 6 0.2 A˚, and rG(O6)2C(N4) 5 2.91 6 0.2 A˚; for AT
base pairs, rA(N1)-T(N3 )5 2.82 6 0.2 A˚, and rA(N6)2T(O4) 5 2.86 6 0.2 A˚experiments. The stereospecific assignment of Leu and Val methyl
groups was achieved using a 15% fractionally 13C-labeled protein. (Wojciak et al., 1999). Loose torsion angle restraints for the DNA
were used to alleviate problems associated with mirror images,(Hb)Cb(CgCd)Hd and (Hb)Cb(CgCdCe)He experiments were used to
assign aromatic proton resonances. covering both A- and B-form DNA conformers (a 5 265 6 508,
b 5 180 6 508, g 5 60 6 508, e 5 180 6 508 and z 5 285 6 508)Interproton distances within the DNA were derived from 2D
1H/1H NOE spectra and (v1, v2)-13C-filtered NOE spectra, at a mixing (Omichinski et al., 1997; Wojciak et al., 1999). In addition, d angles
for all sugar rings were estimated to be 145 6 508, based on (H19,time of 40 ms. Interproton distances within the protein were derived
from 3D 15N- or 13C-separated or 4D 15N, 13C- or 13C, 13C-separated H29) or (H39, H49) cross peak patterns in a DQF-COSY spectrum.
These hydrogen bond and torsion angle restraints for DNA are justi-NOESY experiments, with a mixing time of 100 ms (Cavanagh et al.,
1996). Intermolecular NOEs observable in D2O were identified using fied, because the pattern of NOEs for the DNA is typical of B-DNA.
Weak planarity restraints for base pairs were included during the3D 13C-filtered/13C-separated NOE spectrum at a mixing time of 100
ms. Then, intermolecular interproton distances were derived from simulated-annealing protocol (a force constant of 10 kcal mol21A˚22).
The XPLOR target function also included a quadratic harmonic po-2D (v2)-13C-filtered NOE spectra, and 2D 1H/1H NOE spectra, at a
mixing time of 40 ms. Intermolecular interproton distance restraints, tential term for covalent geometry and a quartic harmonic potential
term for van der Waals repulsion. In the final steps of the structureincluding protein main chain or Arg e-protons, were identified using
the 3D 15N-separated NOE spectrum of perdeuterated, 15N-labeled determination, hydrogen bond restraints within the protein were
included for 13 slowly exchanging protein backbone amides ob-MBD11–75 containing only Arg residues labeled with 13C, 15N, and 1H.
Assignment of arginine guanidinium 1H and 15N chemical shifts was tained at 303 K (pH 6.5) (2.8–3.4 A˚ [N-O], 1.8–2.4 A˚ [H-O]). No protein-
DNA interfacial hydrogen bonds were assumed during the calcula-obtained, using the same sample, as described previously (Yama-
zaki et al., 1995). tion of the complex.
The procedure for calculating the complex structure was essen-Although the MBD-DNA complex is in slow exchange on the
chemical-shift timescale, observation of NOESY cross peaks arising tially as described by Omichinski et al. (1997). First, the structure
of the protein was calculated by simulated annealing using onlyfrom chemical exchange of the two DNA strands at a mixing time
of 120 ms revealed that there was stochastic reversal in the orienta- restraints within the protein. Second, the structure of the complex
was calculated by simulated annealing using all the experimentaltion of the bound MBD relative to the DNA duplex. In the complex,
the asymmetric MBD monomer is bound to the symmetric double- restraints, starting from B-form DNA and the calculated structure
of the protein, and using a variety of protein-DNA orientations withstranded oligonucleotide; thus, each strand of the DNA interacts
with the MBD in a distinctly different way, exhibiting chemical shifts a separation of about 50 A˚. In total, 200 structures of the complex
were calculated. Of these, 81 structures exhibited neither distancethat are different from those of the opposite strand. Therefore, rever-
sal in the orientation of the bound MBD during the NOESY mixing violations greater than 0.3 A˚ nor dihedral violations greater than
5 degrees. These structures were further refined by a simulatedtime generates cross peaks, as has been seen, for example, in the
case of the HIV Protease/inhibitor KNI-529 (Katoh et al., 1999). annealing procedure. Finally, the 20 structures with the lowest en-
ergy were selected and analyzed with MOLMOL (Koradi et al., 1996),At a mixing time of 120 ms, we observed several cross peaks in
the NOESY spectra, arising from a combined effect of chemical and PROCHECK-NMR software (Laskowski et al., 1996). The statis-
tics of these structures are listed in Table S1. All figures of molecularexchange and NOE. We distinguished cross peaks due to chemical
exchange by measuring NOE spectra at a variety of mixing times structures were drawn with MOLMOL or GRASP (Nicholls et al.,
1991).(40, 60, and 120 ms) over a range of temperatures (from 15 to 358C),
as described previously (Katoh et al., 1999). The build-up rates of The protein-DNA hydrogen bonds illustrated in Figure 4B are ob-
served in most members of the NMR ensemble, except for thethese exchange-originating cross peaks were found to be strongly
temperature-dependent, increasing as the temperature rose. We hydrogen bond from the guanidinium of Arg-44 to either N7 or O6
of G19, or to both of them. This Arg-44-G19 hydrogen bond wasalso measured ROESY spectra (gB1 5 2.5 kHz, mixing time 5 40
ms) to identify cross peaks arising solely from chemical exchange. assumed on the basis of the following observations. First, single
substitution of Arg-44 to either alanine or lysine abolished DNAIntensities of cross peaks that arose from a combined effect of the
chemical exchange and NOE were sufficiently small in NOE spectra binding, indicating that Arg-44 is important for DNA binding (Figure
4C). Second, in members of the NMR ensemble, only N7 or O6 ofat a mixing time of 40 ms; thus, all interproton distances within the
DNA and those between the protein and the DNA were derived at G19 and/or O6 of G20 can accept hydrogen bond from the Nh atom
of Arg-44; no other group in the DNA was found to accept the bond.this mixing time. Despite this technical difficulty, we collected 91
Cell
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Of these two Arg-44-base contacts, the significance, or existence, Cavanagh, J., Fairbrother, W.J., Palmer, A.G., III, and Skelton, N.J.
(1996). Protein NMR Spectroscopy (San Diego: Academic Press).of the Arg-44-G20 hydrogen bond can be excluded because MBD
of MBD1 can bind efficiently to DNA of the sequence 59-GATCGAm5 Chandler, S.P., Guschin, D., Landsberger, N., and Wolffe, A.P. (1999).
CGACGTAC-39 (data not shown). This observation indicates that for The methyl-CpG binding transcriptional repressor MeCP2 stably
specific binding, the base following the m5CG sequence (positions 8 associates with nucleosomal DNA. Biochemistry 38, 7008–7018.
and 20 in Figure 1B) can also be adenine or thymine. Taken together,
Chen, R.Z., Pettersson, U., Beard, C., Jackson-Grusby, L., and Jae-these observations indicate that the Arg-44-G19 hydrogen bond
nisch, R. (1998). DNA hypomethylation leads to elevated mutationfound in the NMR ensemble is significant in DNA recognition. How-
rates. Nature 395, 89–93.ever, no additional restraints besides the NOE-derived ones were
Connolly, K.M., Ilangovan, U., Wojciak, J.M., Iwahara, M., and Clubb,applied to the side chain of Arg-44 or Arg-22 during the structure
R.T. (2000). Major groove recognition by three-stranded beta-calculation. The interfacial NOE restraints involving these residues
sheets: affinity determinants and conserved structural features. J.included: for Arg-44, Ha-mC18(methyl), Hb-C17(H29), -mC18(H29
Mol. Biol. 300, 841–856.and methyl), -[C17(H6) or mC18(H6)], Hg-mC18(H29 and methyl),
-[C17(H6) or mC18(H6)], Hd-mC18(H6 and methyl), He-mC18(methyl); Cornilescu, G., Delaglio, F., and Bax, A. (1999). Protein backbone
for Arg-22, Ha-C5(H49), -mC6(H29), Hg-mC6(H6 and methyl), Hd- angle restraints from searching a database for protein chemical shift
mC6(H29,H299,H39, H6 and methyl), -G7(H8), He-mC6(H6 and and sequence homology. J. Biomol. NMR 13, 289–302.
methyl), -G7(H8), HN-[mC6(H39) or C5(H39)]. Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson,
G.P., Gao, X., Wright, F.A., Feramisco, J.D., Peltomaki, P., Lang,
Mutational Analyses J.C., et al. (2000). Aberrant CpG-island methylation has non-random
Vector constructs containing mutated MBDs were prepared, and and tumour-type-specific patterns. Nat. Genet. 24, 132–138.
the GST-MBD fusion proteins were purified, as described previously
Cross, S.H., Meehan, R.R., Nan, X., and Bird, A. (1997). A component
(Ohki et al., 1999). For each mutant except S45A, we checked that
of the transcriptional repressor MeCP1 shares a motif with DNA
the overall native fold had not been disrupted by 1H-15N HSQC spec-
methyltransferase and HRX proteins. Nat. Genet. 16, 256–259.
tra, as described previously (Ohki et al., 1999). We could not obtain
Dragich, J., Houwink-Manville, I., and Schanen, C. (2000). Rett syn-enough of the S45A MBD for HSQC measurements; however, a 1H
drome: a surprising result of mutation in MECP2. Hum. Mol. Genet.NMR spectrum of S45A showed no evidence of disruption of the
9, 2365–2375.native fold (Ohki et al., 1999). DNA binding reactions were carried
out in 10 ml of 10 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 5 mM DTT, Free, A., Wakefield, R.I., Smith, B.O., Dryden, D.T., Barlow, P.N.,
and 5% glycerol. The mixtures contained 1.7 mg of each purified and Bird, A.P. (2001). DNA Recognition by the Methyl-CpG binding
protein and 74 ng of the methylated or unmethylated 12-mer oligonu- Domain of MeCP2. J. Biol. Chem. 276, 3353–3360.
cleotide duplex. Reactions were carried out for 30 min at room Fujita, N., Takebayashi, S., Okumura, K., Kudo, S., Chiba, T., Saya,
temperature. The binding reaction mixtures were loaded on a 10% H., and Nakao, M. (1999). Methylation-mediated transcriptional si-
acrylamide gel and run in TBE; the gels were stained with SYBR lencing in euchromatin by methyl-CpG binding protein MBD1 iso-
green I (Molecular Probes). Of those shown in Figure 4C, we have forms. Mol. Cell. Biol. 19, 6415–6426.
previously reported DNA binding activities of the following mutants:
Fujita, N., Shimotake, N., Ohki, I., Chiba, T., Saya, H., Shirakawa,R22A, R30A, D32A, Y34A, R44A, S45A, and Y52A (Ohki et al., 1999).
M., and Nakao, M. (2000). Mechanism of transcriptional regulation
by methyl-CpG binding protein MBD1. Mol. Cell. Biol. 20, 5107–5118.
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